National Cell Manufacturing Consortium (NCMC) Roadmap, NIIMBL and ARMI
Achieving Large Scale, Cost-effective, Reproducible Manufacturing of High Quality Therapeutic Cells: A Roadmap to 2015
This talk will detail the roadmap and recent updates from the National Cell Manufacturing Consortium for achieving large-scale, reproducible manufacturing of high quality cells, both stem cells and immune cells as well as genetically modified cells. We will also discuss various national and international private-public partnerships available for industry and academia to engage with in this space and leverage federal and philanthropic resources to further advance their mission.
Krishnendu Roy, Ph.D. -
Robert A. Milton Chair, Director, Marcus Center for Cell-Therapy Characterization and Manufacturing,
Georgia Tech and Emory University